Genetic testing for nonclassical 21-hydroxylase deficiency CAH was recommended but declined, although based on the personal and family history, it is assumed that a mutation in the CYP21A2 gene would be most consistent with the phenotype. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.